Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Keith Nord

Orthopaedic Surgery Jackson, TN Medical Doctor

NPI 1033180948 CMS profile 183457

111 Stonebridge Blvd, Jackson, TN 38305

Open in the dashboard

General payments

$286,449

161 records reported · program years 2019–2025

Research payments

$2,844

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$75,393 paid to institutions, not to them · program year 2024

Through program year 2025, Keith Nord of Jackson, TN is reported in the CMS Open Payments database as having received $286,449 across 161 general payments and $2,844 in research payments paid to them. Separately, studies naming them as principal investigator received $75,393 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,528 21
2024 General $1,458 17
2023 General $1,978 21
2023 Research $444 2
2022 General $64,220 38
2021 General $76,876 26
2020 General $61,477 13
2020 Research $2,400 1
2019 General $76,912 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Keith Nord
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Keith Nord were reported at $3,528. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Keith Nord Orthopaedic Surgery median Middle half National median
2019 $76,912 $644 $140–$2,844 $163
2020 $61,477 $312 $75–$1,860 $114
2021 $76,876 $520 $117–$2,495 $132
2022 $64,220 $598 $128–$2,731 $149
2023 $1,978 $461 $128–$2,264 $160
2024 $1,458 $497 $134–$2,475 $164
2025 $3,528 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $277,471 58 payments
  2. Dunamis Medical, LLC $2,816 4 payments
  3. Gentleman Orthopedic Solutions $2,313 8 payments
  4. Sonex Health, Inc. $1,285 9 payments
  5. AxoGen $475 4 payments
  6. Smith+Nephew, Inc. $221 3 payments
  7. DePuy Synthes Sales Inc. $195 6 payments
  8. Acumed LLC $189 1 payment
  9. Stryker Corporation $176 2 payments
  10. Endo Pharmaceuticals Inc. $176 12 payments
  11. Other $1,131 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $269,689 16 payments
  2. Education $6,464 6 payments
  3. Food and Beverage $4,310 128 payments
  4. Travel and Lodging $4,294 10 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,693 1 payment
Products named General payments · program years 2019–2025
  1. ARTHREX Shoulder - Instruments - Hand Instruments - Graspers & Retrievers $134,916 8 payments
  2. ARTHREX Shoulder - Instruments - Hand Instruments - Graspers & Retrievers $134,916 8 payments
  3. ARTHREX Shoulder - Instruments - Hand Instruments - Graspers & Retrievers $134,916 8 payments
  4. ARTHREX Shoulder - Instruments - Hand Instruments - Graspers & Retrievers $134,916 8 payments
  5. SHOULDER INSTRUMENTS HAND INSTRUMENTS GRASPERS & RETRIEVERS $134,773 8 payments
  6. KNEE & HIP INSTRUMENTS HIP REUSABLE $134,773 8 payments
  7. ARTHREX Shoulder - Instruments - Hand Instruments - Graspers & Retrievers $36,943 2 payments
  8. ARTHREX Shoulder - Instruments - Hand Instruments - Graspers & Retrievers $36,532 2 payments
  9. ARTHREX Shoulder - Instruments - Hand Instruments - Graspers & Retrievers $29,841 2 payments
  10. ARTHREX Knee & Hip - Instruments - Hip - Reusable $15,957 1 payment
  11. Other $19,943 113 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Dunamis Medical, LLC $2,844 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

364

Median for Orthopedic Surgery: 203

Drug cost

$2,977

Median for Orthopedic Surgery: $1,433

Branded share of claims

20.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 98 $872
Celecoxib Generic 45 $564
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 58 $554
Diclofenac Sodium Generic 30 $323
Meloxicam Generic 43 $159
Nabumetone Generic 11 $154
Amoxicillin Generic 19 $92
Methocarbamol Generic 12 $90
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 16 $66
Tramadol Hcl Generic 19 $52

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 144 billing codes

Paid by Medicare

$262,403

Of which drugs: $33,106

Medicare patients

427

Average age 74

Services billed

4,911

261 women, 166 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 38%
Ischemic heart disease 37%
Depression 32%
Chronic kidney disease 28%
COPD 25%
Heart failure 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg J3304 Office 27 1,376 $19,030
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 21 28 $11,377
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 83 371 $2,034

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XIAFLEX
  • Endo USA, Inc. $39
  • Endo Pharmaceuticals Inc. $17
$57 — —
Zilretta
  • Pacira Pharmaceuticals Incorporated $10
$10 — 1,376
Exparel
  • Pacira Pharmaceuticals Incorporated $10
$10 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

164 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record